Company Description
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide.
It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.
This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.
The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners.
This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services.
Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Country | United States |
IPO Date | Nov 3, 1995 |
Industry | Medical - Distribution |
Sector | Healthcare |
Employees | 26,000 |
CEO | Stanley M. Bergman CPA |
Contact Details
Address: 135 Duryea Road Melville, New York United States | |
Website | https://www.henryschein.com |
Stock Details
Ticker Symbol | HSIC |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001000228 |
CUSIP Number | 806407102 |
ISIN Number | US8064071025 |
Employer ID | 11-3136595 |
SIC Code | 5047 |
Key Executives
Name | Position |
---|---|
Stanley M. Bergman CPA | Executive Chairman & Chief Executive Officer |
Christopher Pendergast | Senior Vice President & Chief Technology Officer |
Michael Saul Ettinger | Executive Vice President & Chief Operating Officer |
Ronald N. South | Senior Vice President & Chief Financial Officer |
Walter Siegel | Senior Vice President & Chief Legal Officer |
Ann Marie Gothard | Vice President of Global Corporate Media Relations |
Graham Stanley | Vice President of Investor Relations & Strategic Finance Project Officer |
James P. Breslawski CPA | President |
Mark E. Mlotek | Executive Vice President, Chief Strategic Officer & Executive Director |
Olga Timoshkina | Vice President of Corporate Finance, Chief Accounting Officer & Corporate Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 13, 2024 | S-8 | Filing |
Dec 13, 2024 | S-8 | Filing |
Dec 12, 2024 | 4 | Filing |
Nov 20, 2024 | 4 | Filing |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 05, 2024 | 10-Q | Quarterly Report |
Nov 05, 2024 | 8-K | Current Report |
Sep 18, 2024 | 4 | Filing |
Sep 18, 2024 | 4/A | [Amend] Filing |